Prescription drug · ANDA
Acyclovir NDC 68071-2279
Acyclovir 400 mg/1 · Tablet · Oral · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-2279-8 | 68071227908 | 15 TABLET in 1 BOTTLE (68071-2279-8)Marketed from Oct 15, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acyclovir
- Generic name (nonproprietary)
- acyclovir
- Active ingredients
- Acyclovir — 400 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074891
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 68071-2279_1d7831aa-71b0-6028-e063-6294a90a2354SPL ID 1d7831aa-71b0-6028-e063-6294a90a2354SPL set ID b1b999a9-11cc-d6e5-e053-2995a90a5478RxCUI 197311UNII X4HES1O11FUPC 0368071227987
- Pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071227908followed by a unit qualifier and the quantityPackage 68071-2279-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Herpes Zoster Infections: Acyclovir tablets, USP are indicated for the acute treatment of herpes zoster (shingles). Genital Herpes: Acyclovir tablets, USP are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox: Acyclovir tablets, USP are indicated for the treatment of chickenpox (varicella).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074891
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acyclovir | Acyclovir 800 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-228 |
| Acyclovir | Acyclovir 400 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-227 |
| Acyclovir | Acyclovir 800 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4186 |
| Acyclovir | Acyclovir 400 mg/1 | TabletOral | American Health Packaging | 60687-856 |
| Acyclovir | Acyclovir 800 mg/1 | TabletOral | American Health Packaging | 60687-867 |
| Acyclovir | Acyclovir 400 mg/1 | TabletOral | Proficient Rx LP | 71205-371 |
| Acyclovir | Acyclovir 800 mg/1 | TabletOral | Proficient Rx LP | 71205-388 |
| Acyclovir | Acyclovir 400 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1757 |
| Acyclovir | Acyclovir 400 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1645 |